---
title: Crystec Limited (CrystecPharma) vs Porton
slug_a: crystecpharma
slug_b: portonpharma
site: cdmo
review_signal_gate: closed
canonical_path: /compare/crystecpharma/portonpharma
---

# Crystec Limited (CrystecPharma) vs Porton

Side-by-side profile data from each company listing on this directory.

## Crystec Limited (CrystecPharma)

- Profile: [/companies/crystecpharma](/companies/crystecpharma)

Crystec Limited (CrystecPharma) — Crystec Limited (CrystecPharma) is a pharmaceutical technology company that offers its mSAS® supercritical-fluid particle engineering platform to improve the bioavailability, stability and delivery of small and large molecule therapeutics. Its work is aimed at clients developing new and existing medicines.

Services: 4. Modalities: 5. Indications: 1. Locations: 4. Certifications: 0. The strongest documented coverage currently appears in modalities (5).

### Services

- Solid-State Chemistry & Polymorph Screening
- Inhalation & Nasal Dosage Manufacturing
- Process Development
- Formulation Development

### Modalities

- Small Molecule
- Biologics (Monoclonal Antibodies)
- Biologics (Other)
- Oligonucleotide
- Peptide

### Development capabilities

- Formulation development

### Manufacturing capabilities

- Data not yet provided.

## Porton

- Profile: [/companies/portonpharma](/companies/portonpharma)

Porton — Porton is a global CDMO offering integrated manufacturing and development services across small molecules, peptides, oligonucleotides, biologics, and conjugates with specialized capabilities in flow chemistry, biocatalysis, and advanced therapies.

Services: 10. Modalities: 5. Indications: 0. Locations: 10. Certifications: 0. The strongest documented coverage currently appears in services (10).

### Services

- Small Molecule Development & Manufacturing
- API Synthesis & Manufacturing
- Flow Chemistry & Continuous Manufacturing
- Solid-State Chemistry & Polymorph Screening
- ADC (Antibody-Drug Conjugate) Manufacturing
- Bioconjugation Services
- Oligonucleotide Manufacturing
- Peptide Manufacturing
- Process Development
- CMC Analytical Development

### Modalities

- Small Molecule
- Biologics (Other)
- Antibody-Drug Conjugate (ADC)
- Oligonucleotide
- Peptide

### Development capabilities

- Analytical method development
- Solid-state characterization

### Manufacturing capabilities

- Drug Substance (DS)
- Drug Product (DP)
- Flow Chemistry